with CF for such couples. Here we document our general The aim of this study was to assess the outcome of experience with such couples and discuss the clinical advice intracytoplasmic sperm injection (ICSI) with fresh and to couples in the light of increased knowledge of the genotypefrozen-thawed surgically retrieved spermatozoa from men phenotype relationship. Of the 27 couples treated, 15 conceived diagnosed with congenital bilateral absence of the vas a total of 18 clinical pregnancies and 14 livebirths have resulted. , 1995) . Once the analyses were complete, clinical genetic deferens (CBAVD) (Silber et al., 1987) . The initial in-vitro counselling was provided. fertilization (IVF) cycles were notable for poor oocyte fertilization rates with only 15.8% of oocytes inseminated reaching Surgical sperm aspiration cleavage stage (Mathieu et al., 1992) . Since 1993, couples
deferens (CBAVD). Twenty-seven azoospermic men with their partners were treated [25 with CBAVD and two with Materials and methods clinical cystic fibrosis (CF)]. CF gene mutation analysis
The male partner was usually admitted on the day of oocyte retrieval. During the time course of this series, two surgical methods were have been offered intracytoplasmic sperm injection (ICSI) with employed for retrieval of spermatozoa. (i) Microsurgical epididymal (Shrivastav et al., 1994) The samples were diluted with human tubal fluid medium (HTFM) containing 5% serum, centrifuged, and resuspended in HTFM before being incubated at 37°C in 5% CO 2 until required. Whenever assess if spermatozoa exhibiting some motility could be recovered.
If satisfactory motile spermatozoa were recovered, the frozen-thawed spermatozoa were used for subsequent treatment cycles. For a few treatment cycle or at the time of initial assessment and scrotal
Total n (%) 28 24 (86) 20 (83) exploration, resulting in the use of cryopreserved spermatozoa in the initial IVF cycle.
are listed in (Sathanandan et al., 1989) . The azoospermia. Cryopreserved spermatozoa were used for 14 procedure of ICSI has also been previously described and does not couples for a total of 24 cycles with 264 oocytes available for differ from that used for ejaculated spermatozoa (Payne, 1995 (52) were suitable for transfer. One clinical pregnancy occurred from the 12 embryo transfer procedures with the satisfactory livebirth of a girl.
Results
Two pregnancies resulted from cycles in which pre-implantation genetic diagnosis (PGD) by blastomere biopsy was perOf the 25 men with CBAVD, without clinical CF, 15 (60%) carried a single mutation, five (20%) were compound heterozyformed to identify the cystic fibrosis mutation ∆F508 prior to embryo transfer. One couple were ∆F508 heterozygotes and gotes and five (20%) had no mutation identified. These results the other included a female partner who was identified as a mutation could be identified (Lissens et al., 1996) . Our compound heterozygote (see below). A first trimester spontanexperience supports these findings with a similar proportion eous abortion and a live birth resulted. Analysis of the products of heterozygotes (60%), compound heterozygotes (20%) and of conception and blood from the neonate confirmed the 20% without a mutation. There is an increased prevalence of genotype expected from the pre-implantation diagnostic prothe R117H mutation within the CBAVD population. In this cedure (Cui et al., 1995) .
series, of the men with CBAVD (excluding the two with CF), At the request of the parents the CF genotypes of two six of the 25 (24%) of the CF chromosomes identified were children derived from fathers who were ∆F508 heterozygotes R117H. This compares with less than 0.3% incidence of were tested and found to be heterozygotes. Both children are R117H in those patients with classic CF and is similar to the healthy, consistent with their heterozygous genotype.
22% initially reported in CBAVD (Gervais et al., 1993) . Men with CBAVD but without CF gene mutations have a high incidence of urinary tract malformations (Dork et al., Discussion 1997) . This group with urinary tract anomalies represent a CBAVD and CF gene mutations separate clinical entity not related to CF and with a different embryological pathogenesis. In our study the five men without CBAVD occurs in 1 in 1000 men in the population and a CF mutation underwent ultrasound assessment of their renal represents 1-2% of infertile males. Testicular function is tract and two of them had unilateral kidney agenesis. usually not compromised with normal testicular size and
The protein encoded by the CF gene is designated CF consistency, normal concentrations of serum FSH with normal transmembrane conductance regulator (CFTR). In normal indispermatogenesis. Whereas almost all men with cystic fibrosis viduals, five, seven or nine thymidine (T) nucleotides can be have CBAVD, only a small proportion of men with CBAVD identified at the intron 8-exon 9 acceptor splice site of the have a medical history of pancreatic insufficiency, respiratory CFTR gene (Chillon et al., 1995) . The efficiency of splicing disease or chronic sinusitis and it is therefore considered a of exon 9 is thought to modify the phenotypic expression of mild phenotype of cystic fibrosis (Oates and Amos, 1993) .
the CF genotype. Individuals homozygous for the 5T allele Fetal anomaly in the seventh week of gestation during Wolffian have CFTR mRNA resulting in the production of non-funcduct differentiation results in the characteristic pathology.
tional CFTR protein. Some mutations are usually observed The Wolffian duct abnormalities evident in CF and CBAVD with the same T variant; ∆F508 is exclusively associated with indicate a common genetic link confirmed with the identifica-9T as was observed in this series. R117H occurs with two tion of CF gene mutations in both conditions. A review of variants 5T and 7T resulting in different phenotypes although 420 published cases of CBAVD indicated 19% had two mutations, 47% carried a single mutation, and in 34% no no 5T variant of R117H was identified in this series.
Genetic counselling
No significant differences were observed between the use of fresh and cryopreserved spermatozoa, however previously Genetic counselling prior to conception provides an estimate reported smaller series have noted a possible adverse effect of of the likelihood of inheriting a CF mutation from each parent.
cryopreservation (Devroey et al., 1995; Nagy et al., 1995) . The probable phenotype of the child is calculated based upon Our own concurrent larger series of treatment cycles including the female partner's genotype, the severity of the mutation other causes of obstructive azoospermia has not demonstrated identified in the male partner, and the presence of intron 8 a significant reduction in oocyte fertilization rate and embryo splice site variant. Even if CF mutation screening is negative implantation rate. Couples are now advised to consider cryoprethere remains a small possibility that the individual carries an servation of spermatozoa prior to treatment provided that the undetected mutation. For couples in whom the risk of CF post thaw analysis has confirmed motile sperm recovery. is unacceptably high, prenatal diagnosis or pre-implantation Only one of the 17 frozen thawed embryos transferred has genetic diagnosis can be offered. Pre-implantation genetic resulted in a live birth. However, substantially larger numbers diagnosis has been successfully used for ∆F508 and W1282X of embryos will need to be transferred before analysis of but not for the less common mutations.
outcomes will be possible. Female heterozygotes carry a single CF gene mutation and
The clinical examination and follow-up of children born to have no signs of cystic fibrosis. No female equivalent of couples with CBAVD or CF is essential to understand the CBAVD exists due to the different embryological origin of variable phenotypic expression of CF gene mutations. For the definitive female reproductive tract. One female compound most couples in whom the male has CBAVD, the male is a heterozygote was identified. Her genotype (G551D/R117H) carrier of a severe CF gene mutation and the female tests comprised a severe CF mutation (G551D) combined with negative for the group of mutations screened. Therefore the R117H and the 7T allele identified on both chromosomes. She offspring are expected to be asymptomatic (homozygous negareported no past history of CF symptoms, and the assumption tive or asymptomatic heterozygotes). No significant congenital could be made that the R117H was present on a chromosome anomalies have been identified. The eight boys born to CBAVD with an efficient intron 8-exon 9 acceptor splice site. As her fathers were examined and found to have a palpable vas partner was a ∆F508 heterozygote, pre-implantation genetic deferens as expected. diagnosis by blastomere biopsy with PCR amplification was For the two couples in whom the male had been diagnosed performed to avoid the transfer of a ∆F508 compound heterozywith cystic fibrosis, three oocyte retrieval cycles were comgote embryo. Fifty per cent of such embryos would be ∆F508/ pleted. Sperm recovery, sperm cryopreservation, and the ICSI G551D and likely to result in a child with CF. The remaining treatment cycle results were all comparable to the CBAVD men ∆F508 compound heterozygote embryos would be ∆F508/ without clinical cystic fibrosis. These couples both conceived; R117H compound heterozygotes that would be expected to however, one resulted in a miscarriage late in the first trimester, confer a mild phenotype to the child. Transfer of embryos the other pregnancy resulted in the birth of a healthy infant. without the ∆F508 mutation would confer a G551D or R117H
Historically a few reports of fertile CF males have been heterozygote genotype. The presence of an unidentified mutapublished. The demonstration of satisfactory spermatogenesis and this successful delivery of a healthy infant adds to tion together with ∆F508 in the male partner was a remote the evidence confirming the ability of males with CF to possibility which could also result in a compound heterozygote. father children. Despite establishment of a pregnancy, spontaneous miscarriage It is concluded that the advice and treatment options available occurred. Analysis of the products of conception confirmed for infertile couples in whom men have a diagnosis of CBAVD the expected genotype with absence of ∆F508. The second have changed substantially in the course of this series. Analysis couple for whom pre-implantation diagnosis was performed of both partners' medical and family history, cystic fibrosis were ∆F508 heterozygotes. Transfer of homozygous normal genotype, and genetic counselling is required before initiating embryos resulted in a livebirth of a girl with the genotype treatment. The presence of cystic fibrosis mutations is an confirmed from cord blood.
important part of the assessment to permit adequate genetic counselling and the use of pre-implantation genetic diagnosis ICSI outcomes to reduce the likelihood of a child with cystic fibrosis may Earlier studies indicating poor oocyte fertilization rate and need to be considered. Surgical sperm aspiration and the use embryo implantation rate are in contrast to this series. Our of fresh or frozen spermatozoa provide outcomes similar to results are comparable to those with ejaculated spermatozoa, those achieved with ejaculated spermatozoa. Cystic fibrosis and the implantation rates are higher than those achieved with mutations in the male partner do not appear to compromise routine IVF in our clinic (Payne et al., 1994) . oocyte fertilization, embryo implantation rates, or the opportunFor the two couples in whom the male partner were carriers ity for healthy live births. However the total number of live of either the R117H or R117C CF mutation, pregnancy did births reported remains small and continued study will be not occur despite the transfer of 25 embryos over nine cycles.
required to provide sufficient information to counsel couples Embryos derived from males with compound heterozygote contemplating treatment. ∆F508/R117H genotypes demonstrated a satisfactory embryo implantation rate. Larger studies will be necessary to establish
